Drugs / Desmetramadol
Desmetramadol
also known as
Omnitram · Mono-o-demethyltramadol · O-demethyltramadol · O-desmethyl-cis-tramadol · O-dsmt
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT04683926 | Jan 2021 | — | Syntrix Biosystems, Inc. | Completed | No outcome recorded |
| Phase 1 | NCT03312777 | Oct → Dec 2017 | — | Syntrix Biosystems, Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT03664921 | Nov 2018 → Aug 2020 | chronic pain syndrome, diabetic polyneuropathy, neuropathy, painful | Syntrix Biosystems, Inc. | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02205554 Comparator | Aug → Oct 2014 | — | Syntrix Biosystems, Inc. | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Desmetramadol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04683926 ↗ |
| Known as | Mono-o-demethyltramadol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650315 ↗ |
| Known as | O-demethyltramadol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650315 ↗ |
| Known as | O-desmethyl-cis-tramadol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650315 ↗ |
| Known as | O-dsmt | ChEMBL registry synonym — accepted as the source's own label CHEMBL4650315 ↗ |
| Known as | Omnitram | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02205554 ↗ |
| Modality | Small molecule | — CHEMBL4650315 ↗ |
| Route | Oral | “following oral administration of 9 doses healthy subjects” NCT02205554 ↗ |